May 20, 2024· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2023-D-5616-0003
Comments from the Consumer Healthcare Products Association (CHPA).
FDANonrulemakingFDA-2023-D-5616
Annual Reportable Labeling Changes for NDAs and ANDAs for Nonprescription Drug Products; Draft Guidance for Industry; Availability
RIN
—
Last modified
May 20, 2024
Comment window
closed 806d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between May 20, 2024 and May 20, 2024. 0 other organizations filed here. The comment window closed 806d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%